# US 2013/0252250 A1 · Cloned transmembrane receptor for 24-hydroxylated vitamin d compounds and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0252250 A1
- Document ID: US20130252250A1
- Status: Published application
- Kind: A1
- Application number: 13/906,028
- Filed: 2013-05-30
- Published: 2013-09-26
- Earliest claimed: 2009-06-01
- Assignees: Shriners Hospital For Children
- Applicants: Shriners Hospital For Children
- Inventors: Rene St-Arnaud
- Web page: https://patentgrep.com/patent/US20130252250A1

## CPC

- G01N 33/5088: {of vertebrates}
- A61K 49/0008: {Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure}
- C07K 14/705: Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)}
- G01N 33/5041: {involving analysis of members of signalling pathways}
- G01N 33/6872: {Intracellular protein regulatory factors and their receptors, e.g. including ion channels}
- G01N 33/82: involving vitamins {or their receptors}
- A01K 2217/056: due to mutation of coding region of the transgene (dominant negative)
- G01N 2800/108: Osteoporosis
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

## Abstract

The instant invention relates to the use of 24-hydroxylated vitamin D compounds as therapeutics in mammalian bone fracture repair. In addition, the instant invention relates to novel 24-hydroxylated vitamin D compound receptors which can be employed in the development of compounds capable of facilitating fracture repair in animals. The instant invention also relates to nucleic acids encoding such receptors as well as vectors, host cells, transgenic animals comprising such nucleic acids and screening assays employing such receptors.

## Claims

### Claim 1

A method of identifying a compound suitable for enhancing bone fracture repair comprising:
(a) administering a candidate compound capable of binding to a 24-hydroxylated vitamin D compound receptor to an animal; and
(b) determining whether the animal exhibits a change bone fracture repair, as compared with an animal to which the candidate compound has not been administered;
thereby identifying a compound for enhancing bone fracture repair.

### Claim 2 (depends on 1)

The method of claim 1, wherein the 24-hydroxylated vitamin D compound receptor comprises an amino acid sequence shown in SEQ ID NO: 1 or a sequence having at least 90% sequence identity thereto.

### Claim 3 (depends on 1)

The method of claim 1, wherein the animal expresses a functional 24-hydroxylated vitamin D compound receptor.

### Claim 4 (depends on 1)

The method of claim 1, wherein the animal is a wild type animal.

### Claim 5 (depends on 1)

The method of claim 1, wherein the animal is a rodent.

### Claim 6 (depends on 1)

The method of claim 1, wherein the animal is a mouse.
